A detailed history of Heritage Wealth Advisors transactions in Vaxart, Inc. stock. As of the latest transaction made, Heritage Wealth Advisors holds 21,780 shares of VXRT stock, worth $13,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,780
Previous 21,780 -0.0%
Holding current value
$13,285
Previous $14,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Dec 12, 2024

BUY
$0.53 - $1.3 $1,152 - $2,827
2,175 Added 11.09%
21,780 $14,000
Q2 2024

Aug 05, 2024

BUY
$0.53 - $1.3 $11,249 - $27,592
21,225 Added 3824.32%
21,780 $14,000
Q1 2024

Dec 12, 2024

BUY
$0.56 - $1.41 $725 - $1,827
1,296 Added 7.08%
19,605 $25,000
Q1 2024

May 08, 2024

SELL
$0.56 - $1.41 $9,942 - $25,033
-17,754 Reduced 96.97%
555 $0
Q4 2023

Dec 12, 2024

BUY
$0.57 - $0.85 $4,764 - $7,105
8,359 Added 84.01%
18,309 $10,000
Q4 2023

Feb 09, 2024

BUY
$0.57 - $0.85 $4,764 - $7,105
8,359 Added 84.01%
18,309 $10,000
Q2 2023

Dec 12, 2024

SELL
$0.6 - $1.41 $7,098 - $16,680
-11,830 Reduced 54.32%
9,950 $7,000
Q3 2022

Dec 12, 2024

SELL
$2.09 - $4.5 $24,724 - $53,235
-11,830 Reduced 54.32%
9,950 $21,000
Q4 2020

Feb 01, 2021

BUY
$3.5 - $7.98 $25,375 - $57,855
7,250 Added 268.52%
9,950 $57,000
Q2 2020

Jul 17, 2020

BUY
$1.68 - $8.85 $4,191 - $22,080
2,495 Added 1217.07%
2,700 $23,000
Q2 2020

Jul 17, 2020

SELL
$1.68 - $8.85 $4,191 - $22,080
-2,495 Reduced 92.41%
205 $23,000
Q1 2020

May 05, 2020

BUY
$0.34 - $2.87 $918 - $7,749
2,700 New
2,700 $4,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $77.2M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Heritage Wealth Advisors Portfolio

Follow Heritage Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.